Belgium· BE-AMP-SAM104772-00
Colestid 5 g
A colestipol product containing colestipol hydrochloride, registered in Belgium by Pfizer. The same ATC class is registered in 7 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Colestipol is registered in 7 of 19 countries.
Countries holding a registration under ATC C10AC02 (colestipol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Colestipol · ATC C10AC02
7 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Norwayprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Colestipol Hydrochloride
- Manufacturer
- Pfizer
- Country
- Belgium (BE)
- ATC code
- C10AC02
- ATC class
- Colestipol
- Defined daily dose
- 20 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0031161
- be_apb0703314
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
70 interactions on record for colestipol.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Colestipol · interactions on record
70 records
- 3 severe
- 54 moderate
- 8 minor
Most severe, free to view
- Mycophenolic acidL04AA06severe
- TeriflunomidL04AA31severe
- TeriflunomideL04AK02severe
- Chenodeoxycholic acidA05AA01moderate
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Colestipol in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0f36f88f-185f-480a-b421-57ae95fcf0da GET /v1/drugs/0f36f88f-185f-480a-b421-57ae95fcf0da?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granules for oral suspension",
"source": "afmps",
"status": "REVOKED",
"name_en": "Colestid 5 g",
"name_fr": "Colestid 5 g",
"name_nl": "Colestid 5 g",
"amp_code": "SAM104772-00",
"strengths": [
"5000.0000",
"5000.0000"
],
"pack_count": 2,
"substances": [
"Colestipol Hydrochloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Colestipol",
"authorisation_numbers": [
"BE104772"
]
}See everything about colestipol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.